I think the EUA would end all placebo controlled trials at least in the US. A phase 4 trial would then start after the EUA is granted where there are no placebo patients. Since leronlimab's regular trial didn't have stat sig on mortality maybe they want a more robust ACTIV trial so that stat sig on mortality can be obtained.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.